What is Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine?

Category: Prescription Drugs

Most popular types: Complera Eviplera

false

The antiretroviral drugs rilpivirine, tenofovir disoproxil fumarate, and emtricitabine, and are combined to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 5
Mild 2
None 13

Commonly reported side effects and conditions associated with Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Side effect Patients Percentage
Diarrhea 2
Acid reflux 1
Burning nerve pain in right foot 1
Decreased appetite 1
Erectile dysfunction 1
Fatigue 1

Show all 9 reported side effects

Dosages

Based on patients currently taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Dosage Patients Percentage
1 tablet(s) daily 1

Why patients stopped taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 4
Other 2
Doctor's advice 1
Personal research 1
See all 6 patients who've stopped taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Duration

Currently taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Duration Patients Percentage
5 - 10 years 1

Stopped taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 2
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 16
Usually 4
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 2
A little hard to take 7
Not at all hard to take 10
Cost per month
Cost per month Evaluations Percentage
$200+ 2
$100-199 0
$50-99 2
$25-49 2
< $25 8
Not specified 6

What people switch to and from

Patients started taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine after stopping:

Treatment Patients Percentage
Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate (Atripla) 4

Patients stopped taking Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine and switched to:

Treatment Patients Percentage
Rilpivirine-Tenofovir alafenamide-Emtricitabine (Odefsey) 3
Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide (Genvoya) 1
Dolutegravir (DTG) (Tivicay) 1
Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate (Atripla) 1
Emtricitabine-Tenofovir disoproxil fumarate (Truvada) 1

Show all 6 treatments patients report switching to

Last updated:

1 patient evaluation for Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine

Mar 20, 2015 (Started Jun 21, 2014)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 1 capsule(s) Daily
Advice & Tips: taking Complera(US)/Eviplera(EU) needs an adequate volume/calories mix in food: i decided to have a rich breakfast (>500 calories) I switched to Complera/Eviplera due to persisting morning dizzines after efavirenz: the result was great!
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine